Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Ciprofloxacin
United Therapeutics Europe Ltd
Acute Lymphoblastic Leukaemia - Category
1 trial -
Ciprofol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sedation
1 trial -
Citalopram
COGNITION THERAPEUTICS INC
Antidepressive Agents, Second-Generation
1 trial -
Citalopram
United Therapeutics Europe Ltd
Low Mood
1 trial -
Citrus Limonoid Beverage
United Therapeutics Europe Ltd
Hypercholesterolemia
1 trial -
Clarithromycin
Chinese University of Hong Kong
Bronchiectasis Adult
1 trial -
Clarithromycin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Rhinosinusitis
1 trial -
ClearSight HPI Monitoring system
Grace Therapeutics
Anesthesia, Epidural
1 trial -
Clopidogrel
BRIGHT MINDS BIOSCIENCES INC.
Metabolism of Clopidogrel
1 trial -
Clostridium butyricum (live) Tablets(Meiya)
Rocket Pharmaceuticals B.V.
Rectal Cancer
1 trial -
CocoaVia supplement
United Therapeutics Europe Ltd
Cold Exposure
1 trial -
Coenzyme Q10
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Coenzyme Q10
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Disease
1 trial -
Coffee
Hospital Authority, Hong Kong
Insulin Resistance
1 trial -
Cognitive behavioral therapy for anxiety plus benzodiazepine taper
BRIGHT MINDS BIOSCIENCES INC.
Anxiety Disorders
1 trial -
Colchicine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transcatheter Aortic Valve Replacement
1 trial -
Colonoscopy
Takeda
CD
2 trials -
Colostrum supplementation for bone loss
Petros Pharmaceuticals
Osteopenia
1 trial -
Combination Product: Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Combination group
Hospital Authority, Hong Kong
Cardiac Arrest
1 trial -
Combination of chemotherapy and immunotherapy
The First People's Hospital of Lianyungang
Non Small Cell Lung Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
Peking University Third Hospital
Prostate Cancer
1 trial -
Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources